UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populations

Nature communications, 2022-09, Vol.13 (1), p.5651-5651, Article 5651

2022

Volltextzugriff (PDF)

Targeting CRAF kinase in anti-cancer therapy: progress and opportunities

Molecular cancer, 2023-12, Vol.22 (1), p.208-208, Article 208

2023

Volltextzugriff (PDF)

2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells

Journal of pharmacological sciences, 2021-03, Vol.145 (3), p.279-288

2021

Volltextzugriff (PDF)

Persistent nuclear actin filaments inhibit transcription by RNA polymerase II

Journal of cell science, 2016-09, Vol.129 (18), p.3412-3425

2016

Volltextzugriff (PDF)

Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR

Phytotherapy research, 2021-11, Vol.35 (11), p.6377-6388

2021

Volltextzugriff (PDF)

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo

Journal of experimental & clinical cancer research, 2020-06, Vol.39 (1), p.107-14, Article 107

2020

Volltextzugriff (PDF)

Anwulignan is a novel JAK1 inhibitor that suppresses non‐small cell lung cancer growth

Journal of cellular and molecular medicine, 2021-03, Vol.25 (5), p.2645-2654

2021

Volltextzugriff (PDF)

Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer

Molecular cancer, 2022-10, Vol.21 (1), p.1-193, Article 193

2022

Volltextzugriff (PDF)

Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo

Frontiers in oncology, 2021-06, Vol.11, p.648809-648809

2021

Volltextzugriff (PDF)

Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases

Signal transduction and targeted therapy, 2023-04, Vol.8 (1), p.148-148, Article 148

2023

Volltextzugriff (PDF)

Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway

Frontiers in oncology, 2022-01, Vol.11, p.780011-780011

2022

Volltextzugriff (PDF)

Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo

Molecular carcinogenesis, 2024-05, Vol.63 (5), p.991-1008

2024

Volltextzugriff (PDF)

Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosus

Scientific reports, 2019-05, Vol.9 (1), p.8011-13, Article 8011

2019

Volltextzugriff (PDF)

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth

Journal of experimental & clinical cancer research, 2023-04, Vol.42 (1), p.97-97, Article 97

2023

Volltextzugriff (PDF)

Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A

Cell death & disease, 2022-02, Vol.13 (2), p.189-189, Article 189

2022

Volltextzugriff (PDF)

Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase

eLife, 2022-09, Vol.11

2022

Volltextzugriff (PDF)

Targeting integrin αvβ3 with indomethacin inhibits patient‐derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma

Clinical and translational medicine, 2021-10, Vol.11 (10), p.e548-n/a

2021

Volltextzugriff (PDF)

Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo

Acta pharmaceutica Sinica. B, 2022-11, Vol.12 (11), p.4122-4137

2022

Volltextzugriff (PDF)

3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo

Frontiers in cell and developmental biology, 2021-03, Vol.9, p.638174-638174

2021

Volltextzugriff (PDF)

Kcnq 1-5 (Kv7.1-5) potassium channel expression in the adult zebrafish

BMC physiology, 2014-02, Vol.14 (1), Article 1

2014

Volltextzugriff (PDF)

OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer

Cellular and molecular life sciences : CMLS, 2023-09, Vol.80 (9), p.272-272, Article 272

2023

Volltextzugriff (PDF)

A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC

Oncogene, 2022-10, Vol.41 (42), p.4736-4753

2022

Volltextzugriff (PDF)

BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression

Oncogene, 2022-01, Vol.41 (3), p.347-360

2022

Volltextzugriff (PDF)

Targeting FGFR1 by β,β-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models

Phytomedicine (Stuttgart), 2024-07, Vol.129, p.155612, Article 155612

2024

Volltextzugriff (PDF)

Cover Image, Volume 63, Issue 5

Molecular carcinogenesis, 2024-05, Vol.63 (5), p.i-i

2024

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(35)
Dissertationen
(1)

Sprache

Englisch
(36)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populations

Targeting CRAF kinase in anti-cancer therapy: progress and opportunities

2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells

Persistent nuclear actin filaments inhibit transcription by RNA polymerase II

Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo

Anwulignan is a novel JAK1 inhibitor that suppresses non‐small cell lung cancer growth

Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer

Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo

Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases

Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway

Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo

Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosus

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth

Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A

Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase

Targeting integrin αvβ3 with indomethacin inhibits patient‐derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma

Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo

3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo

Kcnq 1-5 (Kv7.1-5) potassium channel expression in the adult zebrafish

OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer

A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC

BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression

Targeting FGFR1 by β,β-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models

Cover Image, Volume 63, Issue 5

Suchergebnisse filtern